All Stories

  1. 2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents
  2. Biosafety Evaluation of 6,7‐Dihydroxy‐3‐(2‐Nitrophenyl)Coumarin in Human Cells
  3. The Role of Trifluoromethyl and Trifluoromethoxy Groups in Medicinal Chemistry: Implications for Drug Design
  4. Exploring Trisubstituted adenine derivatives as adenosine A1 receptor ligands with antagonist activity: Synthesis, biological evaluation and molecular modelling
  5. A New Class of Benzo[b]thiophene-chalcones as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, Molecular Docking and ADME Studies
  6. Seaweeds as Source of Bioactive Pigments with Neuroprotective and/or Anti-Neurodegenerative Activities: Astaxanthin and Fucoxanthin
  7. Empowering Voices: Inspiring Women in Medicinal Chemistry
  8. Empowering Voices: Inspiring Women in Medicinal Chemistry
  9. N-(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria
  10. Front Cover: Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies (ChemMedChem 21/2023)
  11. Study of the DNA damage and cell death in human peripheral blood mononuclear and HepG2/C3A cells exposed to the synthetic 3-(3-hydroxyphenyl)-7-hydroxycoumarin
  12. Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies
  13. Evaluation of in vitro cytotoxic and genotoxic effects of the 3‐(3,4‐dihydroxyphenyl)‐8‐hydroxycoumarin
  14. Oxidation-labile linkers for controlled drug delivery
  15. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies
  16. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies
  17. Propargylamine: an Important Moiety in Drug Discovery
  18. Recent Advances in Biologically Active Coumarins from Marine Sources: Synthesis and Evaluation
  19. Front Cover: Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives (ChemMedChem 21/2022)
  20. Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor
  21. Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives
  22. Cytogenotoxicity assessment of 3‐(3,4‐dihydroxyphenyl)‐7,8‐dihydroxycoumarin on HepG2/C3A cells and leukocytes
  23. Thiocoumarins: From the Synthesis to the Biological Applications
  24. Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance
  25. Treating Neurodegenerative Diseases with Multitarget Drugs: An Interview With Maria João Matos
  26. A comprehensive ethnobotanical profile ofOcimum campechianum(Lamiaceae): from traditional medicine to phytochemical and pharmacological evidences
  27. Single Mutation on Trastuzumab Modulates the Stability of Antibody–Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry
  28. Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold
  29. Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole
  30. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin
  31. 8-Amide and 8-Carbamate Substitution Patterns as Modulators of 7-Hydroxy-4-Methylcoumarin's Antidepressant Profile: Synthesis, MAO Inhibition, Cytotoxicity and Docking Studies
  32. 3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade
  33. Coumarin and Its Derivatives—Editorial
  34. Study of a Selected Series of 3‐ and 4‐Arylcoumarins as Antifungal Agents against Dermatophytic Fungi: T. rubrum and T. mentagrophytes
  35. Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade
  36. Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease
  37. Multitarget Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: An Opportunity or an illusion?
  38. Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance — Call for Papers
  39. Chemical and biological analysis of 4-acyloxy-3-nitrocoumarins as trypanocidal agents
  40. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors
  41. Study of 3-(4’-Nitrobenzamido)coumarin using an Alzheimer’s Disease Model
  42. Trending Topics on Coumarin and Its Derivatives in 2020
  43. Sequential dual site-selective protein labelling enabled by lysine modification
  44. Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans
  45. Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs
  46. 7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation
  47. Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson’s disease: Synthesis, in vitro and in vivo studies
  48. 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?
  49. Coumarin‐Rasagiline Hybrids as Potent and Selective hMAO‐B Inhibitors, Antioxidants, and Neuroprotective Agents
  50. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists
  51. Artificial Intelligence Applied to Flavonoid Data in Food Matrices
  52. Facing Novel Challenges in Neurodegenerative Diseases Drug Discovery: From Small Molecules to Targeted Therapies
  53. Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins
  54. Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification
  55. Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity
  56. Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation
  57. Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation
  58. Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives
  59. Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors
  60. Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
  61. Lysine Bioconjugation on Native Albumin with a Sulfonyl Acrylate Reagent
  62. Coumarin derivatives as promising xanthine oxidase inhibitors
  63. Efficient and irreversible antibody–cysteine bioconjugation using carbonylacrylic reagents
  64. PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
  65. Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates
  66. Unexpected one-step synthesis of 3-benzoyl-2-phenylbenzofurans under Wittig conditions
  67. A silicon-labelled amino acid suitable for late-stage fluorination and unexpected oxidative cleavage reactions in the preparation of a key intermediate in the Strecker synthesis
  68. Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins
  69. Learning from nature: the role of albumin in drug delivery
  70. Trends in patented chromones for skin diseases
  71. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
  72. Chemo- and Regioselective Lysine Modification on Native Proteins
  73. Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
  74. A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging
  75. Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation
  76. Coumarins and adenosine receptors: New perceptions in structure-affinity relationships
  77. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
  78. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies
  79. Heterocyclic Antioxidants in Nature: Coumarins
  80. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins
  81. In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science
  82. MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations
  83. Trends in therapeutic drug conjugates for bacterial diseases: a patent review
  84. Structural elucidation of a series of 6-methyl-3-carboxamidocoumarins
  85. In silico study of new structural alerts of agents clastogenic
  86. Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents
  87. Evaluation of Antioxidant and Antitrypanosomal Properties of a Selected Series of Synthetic 3-Carboxamidocoumarins
  88. Facing Chagas' Disease: Trypanocidal Properties of New Coumarinchalcone Scaffolds
  89. 6-Methyl-2-oxo-N-(quinolin-6-yl)-2H-chromene-3-carboxamide: crystal structure and Hirshfeld surface analysis
  90. Crystal structures of three 6-substituted coumarin-3-carboxamide derivatives
  91. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling
  92. Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold
  93. Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core
  94. Prediction of the total antioxidant capacity of food based on artificial intelligence algorithms
  95. Design, synthesis and antibacterial study of new potent and selective coumarin–chalcone derivatives for the treatment of tenacibaculosis
  96. 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases
  97. Coumarins — An Important Class of Phytochemicals
  98. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold
  99. Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties
  100. In silico clastogenic activity of dietary phenolic acids
  101. Interest of Antioxidant Agents in Parasitic Diseases. The Case Study of Coumarins
  102. Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry
  103. Study of Coumarin-Resveratrol Hybrids as Potent Antioxidant Compounds
  104. Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives
  105. Potential pharmacological uses of chalcones: a patent review (from June 2011 – 2014)
  106. Design and discovery of tyrosinase inhibitors based on a coumarin scaffold
  107. Back Cover: Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors (ChemMedChem 10/2014)
  108. Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors
  109. Synthesis and electrochemical study of new 3-(hydroxyphenyl)benzo[f]coumarins
  110. Insight into the Functional and Structural Properties of 3‐Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition
  111. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases
  112. Chromone: A Valid Scaffold in Medicinal Chemistry
  113. Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives
  114. Comparative study of the 3-phenylcoumarin scaffold: Synthesis, X-ray structural analysis and semiempirical calculations of a selected series of compounds
  115. Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins
  116. QSAR and Complex Network Recognition of miRNAs in Stem Cells
  117. Synthesis and Electrochemical and Biological Studies of Novel Coumarin–Chalcone Hybrid Compounds
  118. Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins
  119. Synthesis, NMR characterization, X-ray structural analysis and theoretical calculations of amide and ester derivatives of the coumarin scaffold
  120. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study
  121. (1S,2S,5S)-2-Methyl-3-oxo-5-(prop-1-en-2-yl)cyclohexane-1-carbonitrile
  122. [(2S,3aR,6aR)-5-Oxohexahydrofuro[3,2-b]furan-2-yl]methyl acetate
  123. MAO Inhibitory Activity of 2‐Arylbenzofurans versus 3‐Arylcoumarins: Synthesis, in vitro Study, and Docking Calculations
  124. ChemInform Abstract: Improved Synthesis of 3‐(Aminoaryl)coumarins.
  125. Editorial (Hot Topic: Monoamine Oxidase as a Target in Medicinal Chemistry and Drug Discovery)
  126. Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
  127. Chalcone-based derivatives as new scaffolds for h A3 adenosine receptor antagonists
  128. Synthesis and Structure-Activity Relationships of Novel Amino/Nitro Substituted 3-Arylcoumarins as Antibacterial Agents
  129. Synthesis of coumarin–chalcone hybrids and evaluation of their antioxidant and trypanocidal properties
  130. New hydroxylated 3-arylcoumarins, synthesis and electrochemical study
  131. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives
  132. N-(2-Oxo-2H-chromen-3-yl)cyclohexanecarboxamide
  133. Looking for New Targets: Simple Coumarins as Antibacterial Agents
  134. Editorial (Hot Topic: Monoamine Oxidase as a Target in Medicinal Chemistry and Drug Discovery)
  135. Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
  136. Monoamine Oxidase Inhibitors: Ten Years of Docking Studies
  137. Looking for New Targets: Simple Coumarins as Antibacterial Agents
  138. Monoamino Oxidase A: An Interesting Pharmacological Target for the Development of Multi-Target QSAR
  139. Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance
  140. 3-Phenylcoumarin
  141. In search for new chemical entities as adenosine receptor ligands: Development of agents based on benzo-γ-pyrone skeleton
  142. Antioxidant and Pro-Oxidant Effects of Polyphenolic Compounds and Structure-Activity Relationship Evidence
  143. Tyrosine-like condensed derivatives as tyrosinase inhibitors
  144. Structural Alerts for Predicting Clastogenic Activity of Pro-oxidant Flavonoid Compounds
  145. Thyroid carcinoma in children and adolescents: A retrospective review
  146. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies
  147. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease
  148. Improved Synthesis of 3-(Aminoaryl)coumarins
  149. Hydroxycoumarins as selective MAO-B inhibitors
  150. Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors
  151. ChemInform Abstract: New Halogenated Phenylcoumarins as Tyrosinase Inhibitors.
  152. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins
  153. New halogenated phenylcoumarins as tyrosinase inhibitors
  154. ChemInform Abstract: Synthesis of 3‐Arylcoumarins via Suzuki Cross‐Coupling Reactions of 3‐Chlorocoumarin.
  155. Synthesis of 3-arylcoumarins via Suzuki-cross-coupling reactions of 3-chlorocoumarin
  156. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors
  157. Regioselective Synthesis of Bromo-Substituted 3-Arylcoumarins
  158. ChemInform Abstract: A New Series of 3‐Phenylcoumarins as Potent and Selective MAO‐B Inhibitors.
  159. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors
  160. Tyrosinase Inhibitor Activity of Coumarin-Resveratrol Hybrids
  161. Synthesis of Regioisomeric Functionalized Benzodifurans and Angelicins
  162. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
  163. Silicones—A Key Ingredient in Cosmetic and Toiletry Formulations